Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review
In Brief: Painter Is AMA President-Elect; FDA Approves Taxol; Protocol Enrolls 150-200 A Month
FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate
FDA Officials Lists ‘Lessons’ Learned Working With AIDS Patient Organizations
FDA Lacks Resources To Deal With Onslaught Of New Cancer Drugs, Friedman Tells Agency
Trending Stories
- In the epicenter of the measles outbreak, “love thy neighbor” does not extend to vaccination rates
A dispatch from Lancaster County - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - As Iowa goes blue, incoming Gov. Rob Sand and Sen. Josh Turek offer plans to address the state’s “cancer crisis”
- Anthony El-Khoueiry named director of USC Norris
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Rachna Shroff, accomplished GI oncologist and “tireless mentor,” dies at 47
Her endowed award will live on









